Login / Signup

Clinical trial and 'real-world' data support switching from a bio-originator to its biosimilar.

Jonathan KayThomas DörnerPaul EmeryTore K KvienFerdinand C Breedveld
Published in: Annals of the rheumatic diseases (2019)
Keyphrases
  • clinical trial
  • electronic health record
  • big data
  • phase ii
  • open label
  • study protocol
  • double blind
  • phase iii
  • artificial intelligence
  • data analysis
  • deep learning
  • placebo controlled